The Scientist - January 8, 2021
Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - January 6, 2021
Liise-anne Pirofski, M.D., discusses a small Argentinian clinical trial that found convalescent plasma was effective in reducing the risk of severe COVID-19 in older patients if they received the treatment within three days of showing symptoms. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
The New York Times - December 28, 2020
Jonathan Alpert, M.D., Ph.D., and Vilma Gabbay, M.D., discuss their published case report on two patients who developed psychosis for the first time after recovering from COVID-19. Dr. Alpert is chair of psychiatry and behavioral sciences at Einstein and Montefiore and Dr. Gabbay is co-director of the Psychiatry Research Institute at Montefiore Einstein.
Dr. Alpert's Profile
Los Angeles Times - November 19, 2020
Eric Meyerowitz, M.D., discusses his study suggesting that transmission of COVID-19 most often occurs indoors in poorly ventilated spaces, with a large portion originating from people who don’t show symptoms. Dr. Meyerowitz is assistant professor of medicine at Einstein and an internist and infectious disease specialist at Montefiore.
Dr. Meyerowitz's Profile
NIH Diabetes Discoveries & Practice Blog - October 28, 2020
Earle Chambers, Ph.D., M.P.H., discusses social and economic conditions—such as barriers to accessing healthy food, stable housing, and safe recreational areas—and how these factors affect patients' ability to manage their risk of developing diabetes. Dr. Chambers is director of the division of research in the department of family and social medicine and associate professor of family and social medicine and of epidemiology & population health at Einstein and Montefiore.
Dr. Chambers' Profile
NPR - October 25, 2020
Gaetano Santulli, M.D., Ph.D., comments on the damage caused by COVID-19 to the cells that line blood vessels and the resulting increased risk of blood clots throughout the body. Dr. Santulli is assistant professor of medicine and of molecular pharmacology.
Dr. Santulli's Profile
CNN - October 15, 2020
Joe Verghese, M.B.B.S., M.S., comments on a study that found apathy in older adults could be a risk factor for dementia and notes his prior research suggests that addressing apathy could help delay the onset of dementia. Dr. Verghese is chief of geriatrics at Einstein and Montefiore and director of the Montefiore Einstein Center for the Aging Brain.
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The New York Times - October 12, 2020
Kartik Chandran, Ph.D., describes the efforts of a multi-institutional collaboration he is leading to discover a potent, long-lasting antibody that would be effective against a range of coronaviruses, not only the one that causes COVID-19. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - September 25, 2020
Betsy Herold, M.D., describes her new research that may help explain why the novel coronavirus affects children less severely than adults. Dr. Herold is chief of pediatric infectious diseases and vice chair for pediatrics research at Einstein and Montefiore and the Harold and Muriel Block Chair in Pediatrics.
Additional Coverage includes Science News, The Scientist, Associated Press, Yahoo, WebMD, The Telegraph (subscription required), Health Day, Marketwatch, Axios, Becker's Hospital Review
Dr. Herold's ProfileMore coverage on Dr. Herold
Science - September 17, 2020
Matthew Akiyama, M.D., says accelerated decarceration due to the COVID-19 pandemic may have led to less rigorous discharge planning for people in jails and prisons who already have difficulty accessing medical care, treatment for addiction, and other services to help them re-enter society. Dr. Akiyama is assistant professor of medicine at Einstein and an internist at Montefiore.
Dr. Akiyama's Profil
Refinery29 - September 9, 2020
Michael Lipton, M.D., Ph.D., discusses his study on the association between oral contraception use and the size of the brain’s hypothalamus in women. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
The New Yorker - September 8, 2020
Liise-anne Pirofski, M.D., discusses the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Additional Coverage includes Los Angeles Times, The Lancet, CNN, USA Today, Nature, The Atlantic, Wall Street Journal (subscription required ), Associated Press, NPR, LA Times, NBC News, CBS News
More CoverageDr. Pirofski's ProfileMore coverage on Dr. Pirofski
NIH Diabetes Discoveries & Practice Blog - August 26, 2020
Martin Grajower, M.D., offers tips to people with diabetes to help them avoid health problems while fasting. Dr. Grajower is clinical professor of medicine at Einstein and an endocrinologist and internal medicine physician at Montefiore.
Dr. Grajower's Profile
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.